New weight loss drug HS-20094 tested in 200-Person trial
NCT ID NCT06118021
First seen Jun 07, 2026 · Last updated Jun 12, 2026 · Updated 2 times
Summary
This study tested a new drug called HS-20094 in 200 overweight or obese adults to see if it helps reduce body weight. Participants took the drug or a placebo for up to 32 weeks, along with diet and exercise. The goal was to measure weight change and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
-
the Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 100044, China
Conditions
Explore the condition pages connected to this study.